The pilot’s findings come at a time when the CDC noted that 1-in-3 primary care physicians and nurse practitioners do not know what PrEP is despite the promise it has shown to prevent HIV among high-risk groups.
Approximately 35% received the flu shot at a doctor’s office, followed by 27% who received it at a pharmacy.
Aurobindo’s sildenafil tablets are a generic version of Pfizer’s Revatio, which treats pulmonary arterial hypertension.
Despite pre-exposure prophylaxis pills’ efficacy in preventing HIV that’s transmitted sexually or through use of injected drugs, only one-in-three primary care physicians and nurses have heard of it.
The drug, according to IMS Health data for the 12 months eneding Sept. 2015, had combined brand and generic sales of $457 million.
Novartis’ Fluad is a trivalent flu vaccine that contains the adjuvant MF59, an emulsion of squalene oil in water, and is aimed at improving immune response among patients 65 years of age and older.
The Medicare savings that the American College of Physicans says could be saved by focusing on generics is estimated to total $1.4 billion.
Eli Lilly and Co.’s Petrazza in a trial extended the lives of patients who took the drug in combination with two forms of chemotherapy to 11.5 months.
Mylan has introduced its generic of Jazz Pharmaceuticals’ schizophrenia treatment.
Following Monday’s announcement that Pfizer would be merging with Ireland-based company Allergan, some analysts are predicting that Pfizer would split the combined company following the $160 billion deal, Reuters reported. According to the report, the split would likely divide the company’s established products (i.e., generics) unit and its innovative medicines unit, composed of drugs that are still patent-protected. (Reuters)